Your browser doesn't support javascript.
loading
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.
Carotenuto, Pietro; Hedayat, Somaieh; Fassan, Matteo; Cardinale, Vincenzo; Lampis, Andrea; Guzzardo, Vincenza; Vicentini, Caterina; Scarpa, Aldo; Cascione, Luciano; Costantini, Daniele; Carpino, Guido; Alvaro, Domenico; Ghidini, Michele; Trevisani, Francesco; Te Poele, Robert; Salati, Massimiliano; Ventura, Sofia; Vlachogiannis, Georgios; Hahne, Jens C; Boulter, Luke; Forbes, Stuart J; Guest, Rachel V; Cillo, Umberto; Said-Huntingford, Ian; Begum, Ruwaida; Smyth, Elizabeth; Michalarea, Vasiliki; Cunningham, David; Rimassa, Lorenza; Santoro, Armando; Roncalli, Massimo; Kirkin, Vladimir; Clarke, Paul; Workman, Paul; Valeri, Nicola; Braconi, Chiara.
Afiliação
  • Carotenuto P; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
  • Hedayat S; Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
  • Fassan M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Cardinale V; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.
  • Lampis A; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
  • Guzzardo V; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Vicentini C; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.
  • Scarpa A; Department of Pathology, University of Verona, Verona, Italy.
  • Cascione L; Department of Pathology, University of Verona, Verona, Italy.
  • Costantini D; Bioinformatics Core Unit, Institute of Oncology Research, Bellinzona, Switzerland.
  • Carpino G; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
  • Alvaro D; Department of Movement, Human and Health Sciences, University of Rome Foro Italico, Rome, Italy.
  • Ghidini M; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Trevisani F; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
  • Te Poele R; Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
  • Salati M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Ventura S; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.
  • Vlachogiannis G; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
  • Hahne JC; Department of Pathology, University of Verona, Verona, Italy.
  • Boulter L; Bioinformatics Core Unit, Institute of Oncology Research, Bellinzona, Switzerland.
  • Forbes SJ; Department of Movement, Human and Health Sciences, University of Rome Foro Italico, Rome, Italy.
  • Guest RV; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Cillo U; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.
  • Said-Huntingford I; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Begum R; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
  • Smyth E; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
  • Michalarea V; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
  • Cunningham D; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Rimassa L; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Santoro A; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
  • Roncalli M; Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Kirkin V; Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Clarke P; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.
  • Workman P; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
  • Valeri N; The Royal Marsden NHS Trust Surrey and London, Sutton, United Kingdom.
  • Braconi C; The Royal Marsden NHS Trust Surrey and London, Sutton, United Kingdom.
Hepatology ; 72(3): 982-996, 2020 09.
Article em En | MEDLINE | ID: mdl-31879968
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Cisplatino / Colangiocarcinoma / MicroRNAs / Desoxicitidina Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Cisplatino / Colangiocarcinoma / MicroRNAs / Desoxicitidina Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido